Massive Multiplexing Can Deliver a $1 Test for COVID-19

The severe acute respiratory syndrome virus, SARS-CoV-2 (hereafter COVID-19), rapidly achieved global pandemic status, provoking large-scale screening programs in many nations. Their activation makes it imperative to identify methods that can deliver a diagnostic result at low cost. This paper describes an approach which employs sequence variation in the gene coding for its envelope protein as the basis for a scalable, inexpensive test for COVID-19. It achieves this by coupling a simple RNA extraction protocol with low-volume RT-PCR, followed by E-Gel screening and sequencing on high-throughput platforms to analyze 10,000 samples in a run. Slight modifications to the protocol could support screening programs for other known viruses and for viral discovery. Just as the $1,000 genome is transforming medicine, a $1 diagnostic test for viral and bacterial pathogens would represent a major advance for public health.

[1]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[2]  Sandeep Kumar Vashist,et al.  In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends , 2020, Diagnostics.

[3]  R. Dorfman.  The Detection of Defective Members of Large Populations , 1943 .

[4]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[5]  Leonie F. Forth,et al.  Highly efficient library preparation for Ion Torrent sequencing using Y-adapters. , 2019, BioTechniques.

[6]  N. Linton,et al.  Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) , 2020, International Journal of Infectious Diseases.

[7]  X. de Lamballerie,et al.  Evaluation of heating and chemical protocols for inactivating SARS-CoV-2 , 2020, bioRxiv.

[8]  X. Huang,et al.  CAP3: A DNA sequence assembly program. , 1999, Genome research.

[9]  Xavier Duval,et al.  Clinical and virological data of the first cases of COVID-19 in Europe: a case series , 2020, The Lancet Infectious Diseases.

[10]  Joshua M Sharfstein,et al.  Diagnostic Testing for the Novel Coronavirus. , 2020, JAMA.

[11]  Sujeevan Ratnasingham,et al.  A Sequel to Sanger: amplicon sequencing that scales , 2017, bioRxiv.

[12]  G. Lippi,et al.  Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing , 2020, Infection Control & Hospital Epidemiology.

[13]  Colin Renfrew,et al.  Phylogenetic network analysis of SARS-CoV-2 genomes , 2020, Proceedings of the National Academy of Sciences.

[14]  N. Tanner,et al.  Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP , 2020, medRxiv.

[15]  A. Sterrett.  On the Detection of Defective Members of Large Populations , 1957 .

[16]  Hui He,et al.  Integrated DNA and RNA extraction using magnetic beads from viral pathogens causing acute respiratory infections , 2017, Scientific Reports.

[17]  Stefan Elbe,et al.  Data, disease and diplomacy: GISAID's innovative contribution to global health , 2017, Global challenges.

[18]  Jose Lourenco,et al.  Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR , 2020, medRxiv.

[19]  Didier Raoult,et al.  Cost-Effective Pooling of DNA from Nasopharyngeal Swab Samples for Large-Scale Detection of Bacteria by Real-Time PCR , 2014, Journal of Clinical Microbiology.

[20]  A. Shehata,et al.  The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control , 2020, Journal of clinical medicine.

[21]  Martin J. Pollard,et al.  Magnetic bead purification of labeled DNA fragments for high-throughput capillary electrophoresis sequencing. , 2001, BioTechniques.

[22]  Devon Chandler-Brown,et al.  A Highly Scalable and Rapidly Deployable RNA Extraction-Free COVID-19 Assay by Quantitative Sanger Sequencing , 2020, bioRxiv.

[23]  Aviv Regev,et al.  LAMP-Seq: Population-Scale COVID-19 Diagnostics Using Combinatorial Barcoding , 2020, bioRxiv.

[24]  Donna M Bond,et al.  Bio-On-Magnetic-Beads (BOMB): Open platform for high-throughput nucleic acid extraction and manipulation , 2018, bioRxiv.

[25]  Xiliang Wang,et al.  COVID-19: a new challenge for human beings , 2020, Cellular & Molecular Immunology.

[26]  Kwok-Hung Chan,et al.  Consistent Detection of 2019 Novel Coronavirus in Saliva , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.